<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-18T22:51:43Z</responseDate><request verb="GetRecord" identifier="oai:dspace.mit.edu:1721.1/50100" metadataPrefix="dim">https://dspace.mit.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:dspace.mit.edu:1721.1/50100</identifier><datestamp>2022-01-28T18:49:46Z</datestamp><setSpec>com_1721.1_7582</setSpec><setSpec>com_1721.1_7581</setSpec><setSpec>col_1721.1_131023</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Kristala Jones Prather and Roy E. Welsch.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Duffy, Juliet (Juliet Maria)</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="other" lang="en_US">Leaders for Manufacturing Program.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Leaders for Manufacturing Program at MIT</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department">Massachusetts Institute of Technology. Department of Chemical Engineering</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department">Sloan School of Management</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2009-12-10T19:12:33Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2009-12-10T19:12:33Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="copyright" lang="en_US">2009</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2009</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/1721.1/50100</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="oclc" lang="en_US">462153001</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">Thesis (M.B.A.)--Massachusetts Institute of Technology, Sloan School of Management; and, (S.M.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering; in conjunction with the Leaders for Manufacturing Program at MIT, 2009.</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">Includes bibliographical references.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Web 2.0, the ultimate platform for tacit based knowledge work has finally arrived. User driven, collaborative platform based tools including wikis, web mash-ups, discussion boards, linkage based search engines, and tagging have the potential to vastly change how information is managed and how knowledge work is captured. This thesis investigates how the new paradigms and tools of Web 2.0 can be applied to the Pharmaceutical Industry and assist with information management at The Novartis Institute for BioMedical Research (NIBR). Applying Web 2.0 tools to NIBR's chemical compounds, targets, assays, people, and projects in a well thought out framework has the potential to yield tremendous productivity improvements in the drug discovery process. Effectively harnessing the collective intelligence of thousands of scientists within Novartis's worldwide research network will enable a paradigm shift. A large, extremely knowledgeable user community can more effectively annotate metadata, hyperlink to important content, establish tags, and collectively author content. Such activities will not only improve the search ability of information but also allow important scientific connections to emerge linking biology to chemistry and furthering Novartis's understanding of disease.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="statementofresponsibility" lang="en_US">by Juliet Duffy.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">S.M.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">M.B.A.</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="extent" lang="en_US">148 p.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">eng</dim:field>
   <dim:field mdschema="dc" element="publisher" lang="en_US">Massachusetts Institute of Technology</dim:field>
   <dim:field mdschema="dc" element="rights" lang="en_US">M.I.T. theses are protected by &#xd;
copyright. They may be viewed from this source for any purpose, but &#xd;
reproduction or distribution in any format is prohibited without written &#xd;
permission. See provided URL for inquiries about permission.</dim:field>
   <dim:field mdschema="dc" element="rights" qualifier="uri" lang="en_US">http://dspace.mit.edu/handle/1721.1/7582</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Sloan School of Management.</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Chemical Engineering.</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Leaders for Manufacturing Program.</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Information management using Web 2.0 technology</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="dspace" element="authorsordered">false</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="others" element="access-status">unknown</dim:field>
   <dim:field mdschema="others" element="access-status">unknown</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="bd2ae81b-3710-46b8-981c-f4e203827fba">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>eng&lt;/Language>
   	&lt;Title>Information management using Web 2.0 technology&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2009&lt;/PublicationDate>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Duffy, Juliet (Juliet Maria)&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;DisplayName>Massachusetts Institute of Technology&lt;/DisplayName>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;License>http://dspace.mit.edu/handle/1721.1/7582&lt;/License>
    &lt;Keyword>Sloan School of Management.&lt;/Keyword>
    &lt;Keyword>Chemical Engineering.&lt;/Keyword>
    &lt;Keyword>Leaders for Manufacturing Program.&lt;/Keyword>
   	&lt;Abstract>Web 2.0, the ultimate platform for tacit based knowledge work has finally arrived. User driven, collaborative platform based tools including wikis, web mash-ups, discussion boards, linkage based search engines, and tagging have the potential to vastly change how information is managed and how knowledge work is captured. This thesis investigates how the new paradigms and tools of Web 2.0 can be applied to the Pharmaceutical Industry and assist with information management at The Novartis Institute for BioMedical Research (NIBR). Applying Web 2.0 tools to NIBR&amp;apos;s chemical compounds, targets, assays, people, and projects in a well thought out framework has the potential to yield tremendous productivity improvements in the drug discovery process. Effectively harnessing the collective intelligence of thousands of scientists within Novartis&amp;apos;s worldwide research network will enable a paradigm shift. A large, extremely knowledgeable user community can more effectively annotate metadata, hyperlink to important content, establish tags, and collectively author content. Such activities will not only improve the search ability of information but also allow important scientific connections to emerge linking biology to chemistry and furthering Novartis&amp;apos;s understanding of disease.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>